Alcon

medical company

ALC SIX Swiss · home listing ALC NYSE ISIN CH0432492467 SEC CIK 1167379 LEI 549300LDT5AP8S0NBM78
Follow Alcon Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · IFRS
EPS, diluted -
Revenue by quarter
$2.5B
$2.6B
Q2 24 Q2 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$5B$0$5B$10B$15BFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$10.4B$980M
FY24$9.9B$1B
FY23$9.5B$974M
FY22$8.7B$335M
FY21$8.3B$376M
FY20$6.8B−$531M
FY19$7.5B−$656M
FY18$7.2B−$227M
FY17$6.8B$256M
FY16--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%60%FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2555.2%13.1%9.4%
FY2455.6%14.3%10.3%
FY2355.5%11%10.3%
FY2254.5%7.7%3.8%
FY2156.1%7%4.5%
FY2043%−7.1%−7.8%
FY1948.8%−2.5%−8.7%
FY1844.6%−3.5%−3.2%
FY1747.2%−1.1%3.8%
FY16---
Free cash flowOperating cash flow minus capital expenditure
$0$500M$1B$1.5B$2BFY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.7B
FY24$1.6B
FY23$730M
FY22$581M
FY21$645M
FY20$344M
FY19$367M
FY18$616M
FY17$803M
FY16-
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$250M$500M$750M$1BFY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$166M$676M
FY24$130M$0
FY23$116M$0
FY22$100M-
FY21$54M-
FY20$0-
FY19$0-
FY18--
FY17--
FY16--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Alcon
  • Healthcare median
−100%−75%−50%−25%0%25%FY17FY19FY21FY23FY25
Show the numbers
YearAlconHealthcare median
FY259.4%−30.6%
FY2410.3%−47%
FY2310.3%−58%
FY223.8%−80.4%
FY214.5%−71.9%
FY20−7.8%−62.2%
FY19−8.7%−46.3%
FY18−3.2%−49.6%
FY173.8%−45.9%
FY16-−36%